pgµç×Ó¹ÙÍø

Genomics, Proteomics & Bioinformatics 2016ÄêµÚ6ÆÚÄÚÈݼò½é

PGµç×Ó¡¤(Öйú)¹Ù·½ÍøÕ¾

¡¡¡¡2016Ê¥µ®½ÚÖ®¼Ê £¬Genomics, Proteomics & Bioinformatics 2016ÄêµÚ6ÆÚÕýʽÔÚÏß³öÊé £¬±¾ÆÚ¹²Ðû²¼ÎÄÕÂ6ƪ £¬°üÀ¨1ƪµãÆÀ £¬1ƪ×ÊÔ´×ÛÊö £¬3ƪÑо¿ÐÔÎÄÕºÍ1ƪҪÁìÀàÎÄÕ¡£¾ßÌå½éÉÜÈçÏ£º

¡¡¡¡1. Jerry L. Workman²©Ê¿£¨ÃÀ¹ú˹ÍÐÍß˹ҽѧÑо¿Ëù£©µÈÈ˶Ô×éÂѰװͶ¹õ £»¯ÔĶÁÆ÷½á¹¹ÓòµÄÏà¹ØÑо¿×ö³öÁ˵ãÆÀ¡£²î±ðÔĶÁÆ÷¹ØÓÚ×éÂѰ×ÐÞÊÎÖаͶ¹õ £»¯µÄʶ±ð»úÖÆÕâÒ»ÎÊÌâÎÒÃÇ»¹²»ÉõÁ˽â¡£½üÈÕ £¬ÀÌβ©Ê¿ºÍDavid Allis²©Ê¿Ñо¿ÍŶÓÔÚNature Chemical Biology·¢ÎÄ £¬½«°Í¶¹õ £»¯ÔĶÁÆ÷´Óäå½á¹¹Óò¼°YEATS½á¹¹ÓòÀ©Õ¹µ½Ë«PHDָ״½á¹¹Óò £¬Ñо¿±êÃ÷äå½á¹¹Óò¡¢YEATS½á¹¹ÓòºÍË«PHDָ״½á¹¹Óò¾ßÓвî±ðµÄÔĶÁÆ«ºÃÐÔ £¬Ë«PHDָ״½á¹¹Óò¿ÉÒÔͨ¹ýÀûÓÃÊèË®Çé¿öºÍЭͬÇâ¼üʶ±ð½Ï´óµÄõ £»ù»¯ÐÞÊÎ £¬ÀýÈç°Í¶¹õ £»¯¡£ËûÃÇÈÏΪ £¬¸üºÃµØÁ˽âÕâЩ×éÂѰ×ÐÞÊÎÔĶÁ»úÖÆÓÐÖúÓÚÎÒÃǽøÒ»²½½âÎö×éÂѰ×ÐÞÊÎÔÚȾɫÖÊÖØËܺ͵÷¿Ø»ùÒòת¼Àú³ÌÖеÄ×÷Óá£

¡¡¡¡2. Ëæ×ŲâÐò¼¼ÊõµÄ²»¾ø½ø²½ £¬ÑªÒº²¡ÁìÓòµÄ²âÐòÊý¾Ý²úÁ¿³ÊÖ¸ÊýÔö¼Ó £¬Óɴ˽µÉúÁËÖî¶àѪҺ²¡ºÍºìϸ°ûÏà¹ØµÄÊý¾Ý¿â £¬ÎªÑªÒºÑ§¿ÆÑ§Ñо¿ÌṩÁËÖî¶àÑо¿°Ðµã £¬²¢ÇÒΪÁÙ´²Õï¶Ï¡¢ÖÎÁÆÌṩÁ˸»×ãµÄÊý¾Ý´¢±¸ºÍ¿ÆÑ§ÒÀ¾Ý¡£ÎÒËùÆ«Ïò¶«²©Ê¿µÈÈËÕë¶Ôºìϸ°ûºÍºìϸ°ûÏà¹ØÑªÒº²¡µÄÊý¾Ý¿â½øÐÐϵͳÐÔ»ã×Ü £¬¸ÅÊöÁËËüÃǵÄÖ÷ÒªÄÚÈÝ¡¢»ù±¾ÌØÕ÷ºÍ³õ¼¶Ê¹ÓÃÒªÁì £¬Ï£ÍûÄܹ»×ÊÖúѪҺѧÏà¹Ø¿ÆÑÐÈËÔ±¡¢ÁÙ´²Ò½ÉúÒÔ¼°ÏëÒªÁ˽â¸ÃÁìÓòµÄÆäËûÈËÔ±½øÒ»²½Á˽â°×Ѫ²¡¡¢Æ¶ÑªÖ¢¡¢´¿ºìϸ°ûÔÙÉúÕϰ­ÐÔÆ¶ÑªºÍÕý³£ºìϸ°û·¢ÓýµÈ £¬Í¬Ê±Ï£ÍûÄÜÔö¼ÓÈËÃÇʹÓù«¹²Êý¾Ý¿âµÄÒâʶ¡£

¡¡¡¡3. Ò»ÐÍÌÇÄò²¡£¨Type 1 diabetes mellitus, T1D£©ÊÇÒ»ÖÖ×ÔÉíÃâÒßϵͳȱÏݵ¼Öµļ²²¡¡£ÎªÁËϵͳµØÌ½ÌÖT1D»¼ÕßÌåÄÚTÁܰÍϸ°ûµÄ×é³É £¬ºØ½¨¿ü²©Ê¿£¨ÄÏ·½¿Æ¼¼´óѧ£©µÈÈËʹÓøßͨÁ¿ÃâÒß×é¿â²âÐò¼¼ÊõÆÊÎöÁËT1D»¼ÕߺͷÇT1D±ÈÕÕ [±ÈÕÕ°üÀ¨¶þÐÍÌÇÄò²¡£¨T2D£©ºÍ·ÇÌÇÄò²¡] Ñù±¾ÖеÄËùÓÐTÁܰÍϸ°ûÊÜÌ壨T cell receptor, TCR£© £¬·¢Ã÷T1D»¼Õß TCRµÄ¶àÑùÐÔÏà±ÈÓÚ±ÈÕÕ×éÃ÷ÏÔ½µµÍ £¬ÇÒ±£´æ¸ü¶àÓÉÓÚ¼òµ¥TÁܰÍϸ°ûÀ©ÔöÐγɵĴó¿Ë¡£¨highly-expanded clones, HEC£© £¬Í¬Ê±ÔÚ²î±ðµÄT1D»¼ÕßÖз¢Ã÷ÁËһЩ¹²ÏíµÄHEC¡£¸ÃÒªÁìÓпÉÄܳÉΪһ¸öÖØÒªµÄ¹¤¾ß £¬ÓÃÓÚÆÀ¹ÀºÍ¼ì²âT1DÒÔ¼°ÆäËû×ÔÉíÃâÒßϵͳ¼²²¡ £¬Èç¿ÉʹÓöàÑùÐÔ×÷Ϊָ±ê £¬À´Çø·Ö²î±ðÀàÐ͵ÄÌÇÄò²¡µÈ¡£

¡¡¡¡4. ¹ÚÐIJ¡ÊÇÒ»ÀàÅÓ´ó¼²²¡ £¬ÆäÒÅ´«»úÖÆÉæ¼°»ùÒò¼äµÄ·ÇÏßÐÔÏ໥×÷Óà £¬È«»ùÒò×éµ¥ºË¸ÊËá¶à̬ÐÔÊý¾ÝÎªÈ«Ãæ½âÎöÅÓ´ó¼²²¡µÄ¶à»ùÒò»¥×÷¼°Ö²¡·Ö×Óͨ·ÌṩÁË»úÔµ¡£ÈÄÉÜÆæ²©Ê¿£¨¹ã¶«Ò½¿Æ´óѧ£©µÈÈ˶ÔÓ¢¹úÍþ¿µÐÅÍлù½ð»á²¡Àý¿ØÖÆÐ­»áÌṩµÄ¹ÚÐIJ¡Êý¾Ý½øÐÐÁËÉî¶ÈÍÚ¾ò £¬½ÓÄÉÁËlogisticºË»úе»Ø¹éÄ£ÐÍ¡¢»ùÒò»¥×÷ÆÊÎö¡¢ÍøÂçÍØÆËѧÆÊÎöµÈ £¬Ê¶±ðÓë¹ÚÐIJ¡ÓйصÄÒ׸Ðͨ·ºÍ¹¦Ð§Ä£¿é £¬·¢Ã÷¸ÊÓÍÖ¬´úлͨ·£¨hsa00561£©¡¢Õ³¶àÌÇÉúÎïºÏ³Éͨ·£¨hsa00532£©µÈÁùÌõÉúÎïѧͨ·Óë¹ÚÐIJ¡ÏÔÖø¹ØÁª £¬½øÒ»²½¸»¼¯ÆÊÎö»ñµÃ6¸ö¹¦Ð§Ä£¿é¸»¼¯µ½Á×֬øC»îÐÔ£¨GO:0004629£©ºÍϸ°ûÕ³¸½·Ö×Ó(CAMs)µÄ½áºÏ£¨GO:0050839£©µÈGOÌõÄ¿ £¬Ìáʾ¶àÖÖ²î±ð¼²²¡µÄ·Ö×Ó»úÖÆ¿ÉÄÜÓн»²æ £¬±êÃ÷¹ÚÐIJ¡Ö²¡·Ö×Ó»úÖÆÉæ¼°¶à¸öÉúÎïѧͨ·ºÍÒÔ¹¦Ð§Ä£¿éÐÎʽ·¢»Ó¹¦Ð§µÄÒÅ´«±äÒì¡£¸ÃÑо¿Éú³¤ºÍÍêÉÆÁËÅÓ´ó¼²²¡Ò׸Ðͨ·ºÍΣº¦¹¦Ð§Ä£¿éʶ±ðµÄÆÊÎö¿ò¼Ü £¬ÎªÆäËû¼²²¡Ñо¿ÌṩÁËÐÂ˼·¡£

¡¡¡¡5. ÂѰ׾ÞϸÊÇÒ»ÏîÖØÒªµÄÉú»¯Ö¸±ê¡£Axel Tiessen²©Ê¿£¨Ä«Î÷¸çCINVESTAV Unidad Irapuato£©µÈÈËÑо¿·¢Ã÷²î±ðµÄÊÀϵÔÚÂѰ׳¤¶È¡¢ÍâÏÔ×ӽṹºÍ½á¹¹ÓòÊýÁ¿ÉÏÓÐÏÔÖøµÄ²î±ð¡£Ö²ÎïÌØÒìÐÔÂѰױÈÖ²ÎïÔÚÆäËûÕæºËÖÖϵÖеÄÊØ¾ÉͬԴÂѰ×ҪС £»Ö²Îï»ùÒò½öº¬Óж¯Îï»ùÒòÒ»°ëµÄÍâÏÔ×Ó £¬²¢ÇÒÆ½¾ù°üÀ¨µÄ½á¹¹ÓòÒ²±È¶¯ÎïÉÙ¡£ºóÉú¶¯ÎïÂѰ×ÓÉ~10¸öСÍâÏÔ×Ó£¨~176 ¸öºËÜÕËánt£©±àÂë¡£Á´ÐÎÖ²ÎïÆ½¾ùÖ»ÓÐ~5.7ÆäÖеȾÞϸÍâÏÔ×Ó£¨~230nt£©¡£¶àϸ°ûÎïÖÖͨ¹ý±àÂë¸ü¶àµÄÍâÏÔ×ÓÊýÁ¿»ñµÃ¸ü´óµÄÂÑ°× £¬¶ø´ó´ó¶¼µ¥Ï¸°ûÉúÎï½ÓÄɸü´óµÄÍâÏÔ×Ó£¨>400 nt£©¡£ÓëÕæºËÉúÎïÆ½¾ùÖµÏà±È £¬Ö²ÎïÓµÓиü¶à¿ÉÊÇÈ´¸üСµÄÂѰ×ÖÊ¡£ÕâÌåÏÖ׎øÐйâÏàÖúÓõÄÉúÎï¾ßÓÐÌØÒìÐÔ £¬ÌáʾÎÒÃÇÓ¦¸ÃÌØ±ð¹Ø×¢Ò»Ï½ø»¯Çý¶¯Á¦¶ÔÖ²ÎïµÄ»ùÒò×éºÍÂѰ×ÖÊ×éµÄ×÷Óà £¬ÕâΪ½øÒ»²½ÆÊÎöÖ²ÎïÂѰ×ÖÊ×é½ø»¯Éϵıä¸ï¼ÍÂɵÓÚ¨ÁË»ù´¡¡£

¡¡¡¡6. ³¦µÀ¾úȺ¹ØÓÚÈËÀàµÄ½¡¿µºÍ¼²²¡±¬·¢ÆðÖØÒª×÷Óà £¬ÅÅйÎïÖеÄDNAÊÇ´ó´ó¶¼ÈËÀ೦µÀ΢ÉúÎïÑо¿µÄµÚÒ»ÊÖÀ´Ô´¡£Nar Singh Chauhan²©Ê¿£¨Ó¡¶ÈMaharshi Dayanand University£©µÈÈË¿ª·¢ÁËÒ»ÖÖ¿ìËÙ¡¢ÓÐЧ¡¢ÎÞÆ«ºÃÐÔÇÒ¾­¼Ã»®ËãµÄÊèÉ¢¸ß·Ö×ÓÁ¿£¨>23 kb£©Ôª»ùÒò×éDNAµÄÒªÁì(ÿmg·à±ã55.8 ¡À 3.8 ng)¡£ÕâÖÖÒªÁìÄܹ»ºÜºÃµØÊÊÓÃÓÚÐÂÏÊ»òÕß¶³´æµÄÅÅйÎï £»ÓëÆäËû²âÊÔµÄDNAÌáȡҪÁìÏà±È £¬ÓÃÕâÖÖÒªÁìÌáÈ¡ÅÅйÎïÔª»ùÒò×éDNA±£´æÁËÎïÖÖÆ·Ã² £¬²¢ÇÒûÓÐ΢ÉúÎïÆ«ºÃÐÔ £¬Æ½ºâÁËÖÊÁ¿¡¢ÊýÁ¿¡¢Óû§ÓѺÃÐԺ;­¼Ã»®ËãµÈÖî¶àÒòËØ £»¿ÉÊÊÓÃÓÚÃâÅàÑø·¨ÆÊÎöÈËÀ೦µÀ¾úȺ £¬ÎªÈËÀ೦µÀ¾úȺÑо¿ÌṩÁËÒ»¸öÇ¿ÓÐÁ¦µÄÄܿ˷þÌáÈ¡ÅÅйÎïÔª»ùÒò×éDNAÖî¶àÕϰ­µÄÐÂ;¾¶¡£²»¹ý £¬¸ÃÒªÁìÓÃÓÚÆäËûÎïÖÖʱ»¹ÐèҪƾ¾ÝÎïÖÖÌØµã½øÐÐÏàÓ¦µ÷½â¡£

¸½¼þÏÂÔØ£º
ÍøÕ¾µØÍ¼